Schaffer Paul W. 4/A
4/A · Sun BioPharma, Inc. · Filed Sep 24, 2019
Insider Transaction Report
Form 4/AAmended
Schaffer Paul W.
Director
Transactions
- Purchase
Common Stock
2018-05-16+2,000→ 94,420 total - Conversion
Common Stock
2018-05-16+11,756→ 30,665 total
Footnotes (3)
- [F1]Reflects purchase of 5,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- [F2]Pursuant to the "alternate conversion" under the Convertible Promissory Note, approximately $52,902 of outstanding principal and accrued but unpaid interest converted into 11,756 units at a price equal to $4.50 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- [F3]Amended solely to correct balances to reflect reverse stock split effective November 7, 2017.